Inactivation of ribonucleotide reductase in tumour cells and inhibition of tumour cell growth by p-alkoxyphenols

Melanoma Research

Volumn 7, Issue 4, 1997, Pages 288-298

  Wellnitz, U ^a   Potsch S ^b   Garbe, C ^c   Lassmann, G ^d  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

EPR spectroscopy; Growth inhibition; Hepatoma; Leukaemia; Melanoma; P alkoxyphenols; Ribonucleotide reductase

Indexed keywords

4 ALLYLOXYPHENOL; 4 BUTOXYPHENOL; 4 ETHOXYPHENOL; 4 ISOBUTOXYPHENOL; 4 ISOPROPOXYPHENOL; 4 PROPOXYPHENOL; HYDROXYUREA; MEQUINOL; PHENOL DERIVATIVE; RADICAL; RIBONUCLEOTIDE REDUCTASE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INACTIVATION; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANIMALS; CELL DIVISION; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MELANOMA; PHENOLS; RATS; RIBONUCLEOTIDE REDUCTASES; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0030801198     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199708000-00003     Document Type: Article

References (36)

1. Lammers M, Follmann H. The ribonucleotide reductases - a unique group of metalloenzymes essential for cell proliferation. Struct Bonding 1983; 54: 27-91.
2. Reichard P, Ehrenberg A. Ribonucleotide reductase a radical enzyme. Science 1983; 221: 514-519.
3. Sjöberg BM, Gräskind A. Ribonucleotide reductase. Adv Inorg Biochem 1983; 5: 87-110.
4. Thelander L, Reichard P. Reduction of ribonucleotides. Annu Rev Biochem 1979; 48: 133-158.
5. Eriksson S, Gräslund A, Skog S, et al. Cell cycledependent regulation of mammalian ribonucleotide reductase. The S-phase-correlated increase in subunit M2 is regulated by the de novo protein synthesis. J Biol Chem 1984; 259: 11695-11700.
6. Elford HL, Freese M, Passamani E, et al. Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J Biol Chem 1970: 245: 5228-5233.
7. Liermann B, Lassmann G, Langen P. Quenching of tyrosyl radicals of M2 subunit from ribonucleotide reductase in tumor cells by different antitumor agents: an EPR study. Free Radical Biol Med 1990; 9: 1-4.
8. Gao WY, Cara A, Gallo RC, et al. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immundeticiency virus type 1 replication. Proc Natl Acad Sci USA 1993; 90: 8925-8928.
9. Schaper K, Seydel JK, Rosenfeld M, et al. Development of inhibitors of mycobacterial ribonucleotide reductase. Lepr Rev 1986; 57: 254-264.
10. Rubin H, Salem JS, Li L-S, et al. Cloning, sequence determination and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy. Proc Natl Acad Sci USA 1993; 90: 9280-9284.
11. Gräslund A, Sahlin M, Sjöberg B-M. The tyrosyl free radical in ribonucleotide reductase. Environ Health Perspect 1985; 64: 139-149.
12. Nordlund P, Eklund H. Structure and function of the Escherichia coli ribonucleotide reductase protein R2. J Mol Biol 1993; 232: 123-164.
13. Ehrenberg A, Reichard P. Electron spin resonance of the iron-containing protein B2 from ribonucleotide reductase. J Biol Chem 1972; 11: 3485-3488.
14. Akerblom L, Ehrenberg A, Gräslund A, et al. Overproduction of the free radical of ribonucleotide reductase in hydroxyurea-resistant mouse fibroblast 3T6 cells. Proc Natl Acad Sci USA 1981; 78: 2159-2163.
15. Gräslund A, Ehrenberg A, Thelander L. Characterization of the free radical of mammalian ribonucleotide reductase. J Biol Chem 1982; 257: 5711-5715.
16. Lassmann G, Liermann B, Arnold W, et al. Ribonucleotide reductase in melanoma tissue. J Cancer Res Clin Oncol 1991; 117: 91-95.
17. Dewey DL, Butcher FW, Galpine AR. Hydroxyanisole-induced regression of the harding-passey melanoma in mice. J Pathol 1976; 122: 117-127.
18. Morgan BG, O'Neill T, Dewey DL, et al. Treatment of malignant melanoma by intravascular 4-hydroxyanisole. Clin Oncol 1981; 7: 227-234.
19. Riley PA. Hydroxyanisole depigmentation: in-vitro studies. J Pathol 1969; 97: 193-206.
20. Riley PA. Mechanism of pigment-cell toxicity produced by hydroxyanisole. J Pathol 1970; 101: 163-169.
21. Rustin GJ, Stratford MR, Lamont A, et al. Phase I study of intravenous 4-hydroxyanisole. Eur J Cancer 1991; 28A: 1362-1364.
22. Riley PA. Hydroxyanisole. the current status. In: Riley PA, ed. Hydroxyanisole: Recent Advances in Antimelanoma Therapy. Oxford: IRL Press, 1984: 1-10.
23. Elford HL. The effect of hydroxyanisoles on mammalian ribonucleotide reductase. In: Riley PA, ed. Hydroxyanisole: Recent Advances in Anti-melanoma Therapy. Oxford: IRL Press, 1984: 71-75.
24. Naish-Byfield S, Cooksey CJ, Latter AM, et al. In vitro assessment of the structure-activity relationship of tyrosinase-dependent cytotoxicity of a series of substituted phenols. Melanoma Res 1991; 1: 273-287.
25. Smit NPM, Peters K, Menko W, et al. Cytotoxicity of a selected series of substituted phenols towards cultured melanoma cells. Melanoma Res 1992; 2: 295-304.
26. Pötsch S, Drechsler H, Liermann B, et al. p-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs. Mol Pharmacol 1994; 45: 792-796.
27. Pötsch S, Sahlin M, Langelier Y, et al. Reduction of the tyrosyl radical and the iron center in protein R2 of ribonucleotide reductase from mouse, herpes simplex virus and E. coli by p-alkoxyphenols. FEBS Lett 1995; 374:95-99.
28. Pötsch S. Radikalmechanismen bei der Aktivierung und Inaktivieriing der kleinen Untereiheit des wachstumsregulierenden Enzyms Ribonucleotid-Reduktase. Dissertation. Free University Berlin, 1995.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
30. Dotsika EN, Sanderson CJ. A fluorometric assay for determining cell growth in lymphocyte proliferation and lymphokine assays. J Immnnol Methods 1987; 105: 55-62.
31. Lassmann G, Liermann B, Lehmann W, et al. Ribonucleotide reductase in ascites tumor cells detected by electron paramagnetic resonance spectroscopy. Biochem Biophys Res Commun 1985; 132: 1137-1143.
32. Kauppi B, Nielsen BB, Ramaswamy S, et al. The threedimensional structure of mammalian ribonucleotide reductase protein R2 reveals a more accessible ironradical site compared to Escherichia coli R2. J Mol Biol 1996; in press.
33. Nordlund P, Sjöberg BM, Eklund H. Three-dimensional structure of the free radical protein of ribonucleotide reductase. Nature 1990; 345: 593-598.
34. Lassmann G, Pötsch S. Mittel gegen Retroviren, insbesondere zur AIDS-Therapie. Patent A2 P4344645.0, filed at Deutsches Patentamt 24.12.1993.
35. Kulkarni GA, Nathanson L. Specificity of growth inhibition of melanoma by 4-hydroxyanisole. Pigment Cell Res 1989; 2: 40-43.
36. Raaphorst GP, Azzami EI. Response of transformed and normal mouse cell lines to anti-melanin compounds, hyperthermia and radiation. Pigment Cell Res 1992; 5: 25-29.